A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)

Summary

The main purpose of this study is to evaluate the efficacy of crovalimab compared with placebo as an add-on therapy to vitamin K antagonist (VKA) in participants with APS.

Timeline

Start

2026-03-16

Primary completion

2030-03-11

Completion

2030-12-02

Outcome

Outcome not reported

Stopped (Business): “The study was discontinued due to a strategic business/portfolio decision by the sponsor and was not related to any medical or safety issue.”

Drugs

Indications